Julphar
Jean Diab is a seasoned professional with extensive experience in board governance and investment management. Currently serving as a member of the Board of Directors for multiple organizations, including Julphar, RAK Medical & Health Sciences University, American University of Ras Al Khaimah, RAK Hospital, and Planet Pharmacies LLC, since 2021. Jean also holds the position of Senior Director of Investments at the Investment and Development Office (IDO) - Ras Al Khaimah. Previous roles include Senior Director of Private Equity at Kamco Invest and Vice President of Private Equity at Eastgate Capital. Education credentials include a Master’s degree in Finance and Investment from Durham University and a Bachelor’s degree in Economics from the American University of Beirut.
This person is not in any teams
Julphar
2 followers
The Julphar story is one of innovation and leadership. Since our journey began in 1980, our goal has remained the same – to bring better healthcare and a brighter future to families across the globe. And in less than 40 years, we have expanded our network across the Middle East and Africa to become one of the largest pharmaceutical manufacturers in the region. Headquartered in Ras Al Khaimah in the United Arab Emirates, we employ 2,500 people worldwide, and we market our products in more than 50 countries. We have 13 internationally accredited facilities that produce more than half a million medicine boxes a day, including tablets, syrups, suspensions, creams and injectables, and vaccines. Julphar has an extensive portfolio of generic medicines, branded generics, and over-the-counter medicines, as well as APIs (active pharmaceutical ingredients). We develop and manufacture medicines and supplements for everything from the common cold to diabetes.